Cargando…

Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents

ABSTRACT: We reported the synthesis and characterization of a series of azolo- and azino[1,3]thiazinones containing the 2,4-dihydroxyphenyl substituent. The compounds were prepared by a new one-step reaction of aryl-modified sulfinylbis[(2,4-dihydroxyphenyl)methanethione]s and the corresponding amin...

Descripción completa

Detalles Bibliográficos
Autores principales: Matysiak, Joanna, Juszczak, Małgorzata, Karpińska, Monika M., Langner, Ewa, Walczak, Katarzyna, Lemieszek, Marta, Skrzypek, Alicja, Rzeski, Wojciech, Niewiadomy, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498246/
https://www.ncbi.nlm.nih.gov/pubmed/26190864
http://dx.doi.org/10.1007/s00706-015-1453-4
_version_ 1782380593075453952
author Matysiak, Joanna
Juszczak, Małgorzata
Karpińska, Monika M.
Langner, Ewa
Walczak, Katarzyna
Lemieszek, Marta
Skrzypek, Alicja
Rzeski, Wojciech
Niewiadomy, Andrzej
author_facet Matysiak, Joanna
Juszczak, Małgorzata
Karpińska, Monika M.
Langner, Ewa
Walczak, Katarzyna
Lemieszek, Marta
Skrzypek, Alicja
Rzeski, Wojciech
Niewiadomy, Andrzej
author_sort Matysiak, Joanna
collection PubMed
description ABSTRACT: We reported the synthesis and characterization of a series of azolo- and azino[1,3]thiazinones containing the 2,4-dihydroxyphenyl substituent. The compounds were prepared by a new one-step reaction of aryl-modified sulfinylbis[(2,4-dihydroxyphenyl)methanethione]s and the corresponding aminoazolo(azino)carboxamides. Their chemical structures were confirmed by IR, NMR: (1)H, (13)C, HSQC, and EI-MS spectral data. The compounds inhibited proliferation and viability of lung cancer A549, colon cancer HT-29, and glioma C6 cells in a structure- and concentration-dependent manner. The activity of some analogues was below 10 μmol dm(−3) (IC(50)). Glioma C6 cells were the most sensitive to tested compounds. Generally, the derivatives were not toxic for the skin fibroblast HSF culture. Moreover, some of them exerted a protective effect on the treated normal cells. Evaluation of compound properties in silico showed that they possess significant drug-like characteristics and most of them display a low toxicity. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-4498246
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-44982462015-07-15 Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents Matysiak, Joanna Juszczak, Małgorzata Karpińska, Monika M. Langner, Ewa Walczak, Katarzyna Lemieszek, Marta Skrzypek, Alicja Rzeski, Wojciech Niewiadomy, Andrzej Monatsh Chem Original Paper ABSTRACT: We reported the synthesis and characterization of a series of azolo- and azino[1,3]thiazinones containing the 2,4-dihydroxyphenyl substituent. The compounds were prepared by a new one-step reaction of aryl-modified sulfinylbis[(2,4-dihydroxyphenyl)methanethione]s and the corresponding aminoazolo(azino)carboxamides. Their chemical structures were confirmed by IR, NMR: (1)H, (13)C, HSQC, and EI-MS spectral data. The compounds inhibited proliferation and viability of lung cancer A549, colon cancer HT-29, and glioma C6 cells in a structure- and concentration-dependent manner. The activity of some analogues was below 10 μmol dm(−3) (IC(50)). Glioma C6 cells were the most sensitive to tested compounds. Generally, the derivatives were not toxic for the skin fibroblast HSF culture. Moreover, some of them exerted a protective effect on the treated normal cells. Evaluation of compound properties in silico showed that they possess significant drug-like characteristics and most of them display a low toxicity. GRAPHICAL ABSTRACT: [Image: see text] Springer Vienna 2015-04-02 2015 /pmc/articles/PMC4498246/ /pubmed/26190864 http://dx.doi.org/10.1007/s00706-015-1453-4 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Paper
Matysiak, Joanna
Juszczak, Małgorzata
Karpińska, Monika M.
Langner, Ewa
Walczak, Katarzyna
Lemieszek, Marta
Skrzypek, Alicja
Rzeski, Wojciech
Niewiadomy, Andrzej
Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
title Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
title_full Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
title_fullStr Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
title_full_unstemmed Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
title_short Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
title_sort synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498246/
https://www.ncbi.nlm.nih.gov/pubmed/26190864
http://dx.doi.org/10.1007/s00706-015-1453-4
work_keys_str_mv AT matysiakjoanna synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT juszczakmałgorzata synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT karpinskamonikam synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT langnerewa synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT walczakkatarzyna synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT lemieszekmarta synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT skrzypekalicja synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT rzeskiwojciech synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents
AT niewiadomyandrzej synthesischaracterizationandpharmacologicalevaluationofnovelazoloandazinothiazinonescontaining24dihydroxyphenylsubstituentasanticanceragents